A Smartphone-based Application Post-myocardial Infarction to Manage Cardiovascular Disease Risk

Mass General Brigham

Status: Completed

Conditions: Percutaneous Coronary Intervention

Treatments: Other: Wellframe

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT03416920

2017P002582

Details and patient eligibility

About

The investigators aim to evaluate Wellframe, a patient engagement platform that includes a mobile phone application for patients, for its impact on supporting patients who have undergone a percutaneous coronary intervention. The patient mobile app has articles about cardiovascular disease and other health related topics, patient-reported outcomes surveys, physical activity tracking, reminders for medications and upcoming appointments, and two-way communication with a Wellframe Health Advocate. The Wellframe Health Advocate encourages patients to achieve their health goals and stay engaged in their health. The feasibility of onboarding patients to the app and the clinical efficacy of the platform will be evaluated.

Enrollment: 167 patients

Sex: All

Ages: 21 to 85 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

English-speaking PCI: balloon angioplasty, bare-metal stent, or drug-eluting stent at MGH Smartphone or Tablet (iOS or Android)

Exclusion criteria

Recent (within 1mo) illicit substance use or alcohol abuse In-hospital AMI Known pregnancy Dementia or cognitive disability Incarceration

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

167 participants in 1 patient group

Wellframe

Experimental group

Description:

Subjects in this arm will use the Wellframe application for 90 days

Treatment:

Other: Wellframe